Metraipolis › archive › dc_c48ebcb23231
A Comparison of the Efficacy and Safety of Ustekinumab and Upadacitinib in Biologically Experienced Ulcerative Colitis Patients — Europe PMC PMID:41153738
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41153738
- DOI
- 10.3390/biomedicines13102455
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T10:37:47.583Z
- SHA-256 of the archived text
6418e59857855b0572e4ee9ab65c06ee2bde8277d3d2c8cca3e2fc1037358a98- Stable URL of this page
https://metraipolis.com/documento/dc_c48ebcb23231
How to cite
A Comparison of the Efficacy and Safety of Ustekinumab and Upadacitinib in Biologically Experienced Ulcerative Colitis Patients — Europe PMC PMID:41153738 — Europe PMC (en), https://europepmc.org/article/MED/41153738 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c48ebcb23231 (Metraipolis archive dc_c48ebcb23231, sha256 6418e59857855b0572e4ee9ab65c06ee2bde8277d3d2c8cca3e2fc1037358a98)
BibTeX
@misc{dcc48ebcb23231,
title = {A Comparison of the Efficacy and Safety of Ustekinumab and Upadacitinib in Biologically Experienced Ulcerative Colitis Patients — Europe PMC PMID:41153738},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41153738},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c48ebcb23231; sha256 6418e59857855b0572e4ee9ab65c06ee2bde8277d3d2c8cca3e2fc1037358a98},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41153738. Agents can read the archived copy with the MCP tool read_document.